PBIO - Pressure BioSciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.90
+0.43 (+12.39%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close3.47
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume3,370
Market Cap4.3M
Beta2.21
PE Ratio (TTM)-1.03
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – Waters Corporation, Bruker Corporation, General Electric Company, Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (WAT-US, BRKR-US, GE-US, HBIO-US, TMO-US and PKI-US) ... Read more (Read more...)

  • Zacks Small Cap Research5 months ago

    PBIO: Significant Revenue Growth Expected for 2017 and Beyond

    Total revenue for the first quarter 2017 was $0.55 million, as compared to total revenue of $0.51 million for the first quarter 2016, an increase of 8.0%. This increase was primarily attributable to an increase of 19% in the sale of instrument systems, from $332,016 in Q1 2016 to $396,095 in the same quarter of 2017. This decrease was primarily due to reduced R&D expenses combined with increased sales of product and services.

  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube5 months ago

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – Waters Corporation, MOCON, Inc., PerkinElmer, Inc., General Electric Company, Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and Bruker Corporation (WAT-US, MOCO-US, PKI-US, GE-US, HBIO-US, ... Read more (Read more...)

  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
    Capital Cube7 months ago

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – MOCON, Inc., PerkinElmer, Inc., Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and Bruker Corporation (MOCO-US, PKI-US, HBIO-US, TMO-US and BRKR-US) that have also reported ... Read more (Read more...)

  • Benzinga10 months ago

    Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell

    “In a research lab, one of the most critical parts of scientific research is what we call sample preparation. It is absolutely critical that you are as good as you can be when you’re preparing the sample ...

  • Zacks Small Cap Research11 months ago

    PBIO: Update on Third Quarter Financials

    The company expects grant revenue to begin to increase in the fourth quarter of 2016 and continue to increase into 2017. Total revenue decreased to $535,334 in the third quarter 2016 from $580,334 for the third quarter of 2015. Adjusted net loss per common share was $(0.02) for the quarters ended September 30, 2016, compared to net loss per share of (0.03) for third quarter of 2015.